Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06571045
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab 05 mg in Participants With DME
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: